Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06581432
PHASE2

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

This is a study for people with advanced cancer for whom previous treatment was not successful. Adults aged 18 and over with advanced cancer with HER2 alterations can join the study. The purpose of this study is to find out whether a medicine called zongertinib helps people with advanced cancers with HER2 alterations. HER2 alterations can cause cancer. Zongertinib inhibits HER2. Participants are put into 13 groups based on the type of advanced cancer and the type of HER2 alterations they have. All participants take one dose of zongertinib each day. Participants can continue the treatment as long as they benefit from it and can tolerate it. Participants visit the study site regularly. During many of the visits, the doctors check the size of the tumour and whether it has spread to other parts of the body. During all the visits, the doctors check participants' health and take note of any unwanted effects.

Official title: Beamion PANTUMOR-1: A Phase II, Multicentre, Multicohort, Open-label Trial to Evaluate the Efficacy and Safety of Oral Zongertinib (BI 1810631) for the Treatment of Selected HER2-mutated or Overexpressed/Amplified Solid Tumours

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

430

Start Date

2024-10-11

Completion Date

2028-12-29

Last Updated

2026-04-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

Zongertinib

Zongertinib

Locations (83)

Alaska Oncology and Hematology, LLC

Anchorage, Alaska, United States

University of Arizona Comprehensive Cancer Center

Tucson, Arizona, United States

Precision NextGen Oncology

Beverly Hills, California, United States

Scripps Cancer Center Torrey Pines

La Jolla, California, United States

Valkyrie Clinical Trials

Los Angeles, California, United States

Yale University School of Medicine

New Haven, Connecticut, United States

BRCR Global

Tamarac, Florida, United States

Illinois Cancer Specialists

Arlington Heights, Illinois, United States

Community MD Anderson Cancer Center - East Medical Oncology

Indianapolis, Indiana, United States

Maryland Oncology Hematology, Columbia

Columbia, Maryland, United States

Karmanos Cancer Institute

Detroit, Michigan, United States

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Memorial Sloan-Kettering Cancer Center

New York, New York, United States

Taylor Cancer Research Center

Maumee, Ohio, United States

Alliance Cancer Specialists, PC, Wynnewood

Wynnewood, Pennsylvania, United States

Sarah Cannon Research Institute at Mary Crowley

Dallas, Texas, United States

The University of Texas MD Anderson Cancer Center

Houston, Texas, United States

Virginia Cancer Specialists, PC

Fairfax, Virginia, United States

Macquarie University

Macquarie Park, New South Wales, Australia

GenesisCare North Shore

St Leonards, New South Wales, Australia

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

St John of God Subiaco Hospital

Subiaco, Western Australia, Australia

Cancer Research South Australia

Adelaide, Australia

Cliniques Universitaires Saint-Luc

Brussels, Belgium

Edegem - UNIV UZ Antwerpen

Edegem, Belgium

Cross Cancer Institute (University of Alberta)

Edmonton, Alberta, Canada

BC Cancer Agency - Vancouver

Vancouver, British Columbia, Canada

Princess Margaret Cancer Centre

Toronto, Ontario, Canada

Centre Hospitalier de l'Universite de Montreal (CHUM)

Montreal, Quebec, Canada

McGill University Health Centre (MUHC)

Montreal, Quebec, Canada

Peking University First Hospital

Beijing, China

Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine

Hangzhou, China

Anhui Provincial Cancer Hospital

Hefei, China

The First Affiliated Hospital of Nanchang University

Nanchang, China

Shanghai East Hospital

Shanghai, China

Shanghai GoBroad Cancer Hospital

Shanghai, China

Wuhan Union Hospital

Wuhan, China

Henan Cancer Hospital

Zhengzhou, China

INS Bergonie

Bordeaux, France

CTR Georges-François Leclerc

Dijon, France

CTR Leon Berard

Lyon, France

HOP Timone

Marseille, France

HOP la Milétrie

Poitiers, France

Institut Gustave Roussy

Villejuif, France

Justus-Liebig Universität Gießen

Giessen, Germany

Asklepios Kliniken GmbH & Co. KGaA

Hamburg, Germany

Universität Leipzig

Leipzig, Germany

Universitätsklinikum Mannheim GmbH

Mannheim, Germany

Klinikum rechts der Isar der Technischen Universität München

München, Germany

Az. Ospedaliere Umberto I di Ancona

Ancona, Italy

Centro di riferimento Oncologico

Aviano (PN), Italy

Istituto Scientifico Romagnolo

Meldola (FC), Italy

ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy

AOU Università degli Studi della Campania Luigi Vanvitelli

Naples, Italy

Fondazione Policlinico Universitario Campus Bio-medico

Rome, Italy

Aichi Cancer Center Hospital

Aichi, Nagoya, Japan

National Cancer Center Hospital East

Chiba, Kashiwa, Japan

Kyushu University Hospital

Fukuoka, Fukuoka, Japan

Hokkaido University Hospital

Hokkaido, Sapporo, Japan

Okayama University Hospital

Okayama, Okayama, Japan

Osaka International Cancer Institute

Osaka, Osaka, Japan

Shizuoka Cancer Center

Shizuoka, Sunto-gun, Japan

National Cancer Center Hospital

Tokyo, Chuo-ku, Japan

Japanese Foundation for Cancer Research

Tokyo, Koto-ku, Japan

Nederlands Kanker Instituut

Amsterdam, Netherlands

Radboud Universitair Medisch Centrum

Nijmegen, Netherlands

Oslo Universitetssykehus HF, Radiumhospitalet

Oslo, Norway

Pan American Center for Oncology Trials, LLC

Rio Piedras, Puerto Rico

National Cancer Centre Singapore

Singapore, Singapore

Seoul National University Hospital

Seoul, South Korea

Severance Hospital

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Complejo Hospitalario Universitario A Coruña

A Coruña, Spain

Hospital del Mar

Barcelona, Spain

Hospital Universitari Vall d'Hebron

Barcelona, Spain

Clínica Universidad de Navarra - Madrid

Madrid, Spain

Hospital Clínico San Carlos

Madrid, Spain

Clínica Universidad de Navarra

Pamplona, Spain

Hospital Virgen del Rocío

Seville, Spain

Hospital Clinico De Valencia (INCLIVA)

Valencia, Spain

Ninewells Hospital & Medical School

Dundee, United Kingdom

The Christie Hospital

Manchester, United Kingdom